MedPage Endocrinology

Follow for #endocrinology news and coverage of all major endocrinology meetings! Peer-reviewed and #endocrinologist-trusted.

@MedPageToday | #EndoTwitter

[MedPage Endocrinology @MedPageEndo]

Check out @medpagetoday's new medical word guessing game, #Wordosis! Test your knowledge with 6 chances to guess the medical word of the day! #MedTwitter #EndoTwitter

https://t.co/xkUrk0fr0N

[MedPage Today @medpagetoday]

"The study doesn't actually give a stamp of approval to run off and take testosterone." -- Bradley Anawalt, MD, commenting on the results of the #TRAVERSE trial presented at #ENDO2023.
@MedPageEndo @MedPageCardio
https://t.co/tAGGrYxykA

[MedPage Today @medpagetoday]

"This is exciting and a novelty for human medicine." -- Martin Wabitsch, MD, PhD, of @uni_ulm, on the success of high-dose leptin treatment on reversing severe, early-onset #obesity in two children carrying rare genetic variants.
@MedPageEndo
https://t.co/ReSe8Z7Nih

[MedPage Today @medpagetoday]

"I get up every morning and I look at patient messages and half of them are due to #Mounjaro." -- @DrKarlNadolsky, of @HollandHospital, on the shortage of the #diabetes drug #tirzepatide.

https://t.co/40jXoKNZM4 @MedPageEndo @SophNaama

[Karl Nadolsky @DrKarlNadolsky]

All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains

[MedPage Today @medpagetoday]

Evidence is building that #COVID could be a risk factor for developing #diabetes, both type 1 and type 2.

@RifkaSchulmanMD @MedPageID @MedPageEndo
https://t.co/8HxNAHZSvQ

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Effects of #dapagliflozin on #hospitalisations in people with type 2 #diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial https://t.co/4OOalOaT5p #T2D

[UCSF Surgery @UCSFSurgery]

‼️Our transplant surgeons wrote, "Attacking our complex and nuanced organ transplant system without realistic solutions only diverts time and resources from this lifesaving work" in the story that was published by @medpagetoday ➡️ https://t.co/f3hfKnpxWM 👇👇

[Daniel J Drucker @DanielJDrucker]

The cardiovascular era for GLP-1RA started with preclinical data, then was launched by LEADER in 2016 and 7 subsequent CVOTs. How and where does GLP-1 produce a CV benefit? Some thoughts #CVD #T2D #diabetes #Heartdisease #Atherosclerosis @NatRevCardiol https://t.co/Uzeet7DMwR

[MedPage Policy @MedPagePolicy]

Obesity Tied to Density of Food Stores Carrying Less Healthy Options, Report Finds
— Link between obesity and unhealthy food establishments holds in both rural and non-rural areas
https://t.co/2BOPUa4Ghg
By @joycefr @medpagetoday
@urbaninstitute @WaxmanElaine

[Matthew Baker M.D., M.S. @mbake013]

Thank you @medpagetoday for covering our work that shows an association between metformin use and a reduced incidence of osteoarthritis. https://t.co/LCIu8A74QH

[Neil Floch MD @NeilFlochMD]

New #obesity drug has less weight loss and more side effects. But in a growing marketplace - the right price point may make it an option for some patients

Altimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutide | Seeking Alpha https://t.co/hw2qb3D2Vh

[UAEM @uaem]

When patients enroll in #clinicaltrials, they reasonably assume that the research results will be shared with the public, physicians, and fellow patients.

But without FDA enforcement, that's not always the case.

See our piece in @medpagetoday:

https://t.co/kM8D8YImyy

[MedPage Today @medpagetoday]

"We shouldn't be scaring away people who have obesity and obesity-related complications." -- @DrKarlNadolsky commenting on new concerns about muscle loss for patients on #semaglutide (#Wegovy, #Ozempic).

https://t.co/dkWi41ta0i @MedPageEndo @KristinaMFiore

[Karl Nadolsky @DrKarlNadolsky]

Does #Wegovy Shrink Muscle Mass to a concerning degree as raised by @PeterAttiaMD recently? https://t.co/EfmJtDA6sV Check out our comments in this @medpagetoday article

[Scott Isaacs @scottisaacsmd]

In patients with NASH cirrhosis, #semaglutide did not significantly improve fibrosis or #NASH resolution vs. placebo. However, semaglutide improves metabolic syndrome, BMI, liver enzymes, and hepatic steatosis, but not liver stiffness. @DrLoomba @Mayo_liverdoc @schattenbergJ
@novonordisk @TheLancet #NAFLD
https://t.co/8KmoCDIjAA

[Beverly G. Tchang, MD @BevTchangMD]

🔥tip: GLP1s can affect absorption of other #medications

eg) Rybelsus ↑ levothyroxine absorption by 33%

If your patient is experiencing new side effects that you can't attribute directly to the GLP1, they might be absorbing more of their other medications

#medicine #endocrine

[Scott Isaacs @scottisaacsmd]

Sleep deprivation causes weight gain by lowering #leptin and raising #ghrelin levels. https://t.co/00RZ26ERxh

[Theresa Madaline @TMadalineID]

Very excited to share our op-ed on the importance of medical treatment for gender nonconforming youth using a patient-centered approach without political influence ⁦@medpagetoday⁩ ⁦@genevievefri⁩ ⁦@NYCHealthSystem⁩ ⁦@SouthBKHealth⁩ https://t.co/h2xTG8GUXq

[Scott Isaacs @scottisaacsmd]

Teenagers' bad sleep habits are linked to insulin resistance. https://t.co/QsNtABCsbQ

[MedPage Today @medpagetoday]

Announcing our next IG Live! 🎉 Featuring @jeremyfaust, @arghavan_salles, & @ShikhaJainMD, this live discussion will focus on strategies to advance gender equity in the field of medicine.

Tune in on March 17 at 2pm ET! To join, follow us on IG: https://t.co/lcrUUQDrCH @WIMSummit